List view / Grid view
24 April 2015 | By Victoria White
The first patient has been enrolled in a Phase II study evaluating laquinimod, an investigational, oral, immune modulator, for the treatment of PPMS...
24 April 2015 | By Victoria White
Innate Pharma has signed a co-development and commercialisation agreement with AstraZeneca to accelerate and broaden the development of IPH2201...
24 April 2015 | By Victoria White
The CHMP has adopted a positive opinion recommending that Bristol-Myers Squibb’s Opdivo be granted approval for use in patients with advanced melanoma...
24 April 2015 | By Victoria White
The combined spend on research and development (R&D) for the peer group of 35 mid-cap biotech companies increased by nearly $2 billion to reach a total of $9.7 billion in 2014, primarily thanks to top spenders Regeneron and Vertex, says leading research and consulting firm GlobalData.
24 April 2015 | By Victoria White
TxCell has announced an amendment to the Ovasave collaboration option, development and license agreement (Ovasave Agreement) with Trizell...
24 April 2015 | By Victoria White
Young healthcare enthusiasts involved in the European Health Parliament will meet on Friday to push ahead with their ideas on Europe's future healthcare...
Batavia Bioservices has changed its name to Batavia Biosciences as of 23 April 2015. The change will coincide with the launch of a new website and multimedia communication strategy.
24 April 2015 | By Victoria White
Janssen Sciences Ireland UC announced results for its hepatitis C treatment simeprevir at The International Liver Congress™ 2015...
23 April 2015 | By Victoria White
Results announced from several Phase 2 clinical studies evaluating uses of Harvoni and other Sovaldi-based regimens for the treatment of HCV infection...
23 April 2015 | By Victoria White
The saturated European market for infant care solutions has received fresh impetus from the rising incidence of preterm births, reports Frost & Sullivan...
23 April 2015 | By Victoria White
Napp and a group of experts in the fields of pain management and dementia care have launched a training resource to help carers identify signs of pain...
23 April 2015 | By Victoria White
A surgical team has completed the world’s first clinical procedure using cold plasma for the selective killing of cancerous tissue...
23 April 2015 | By Victoria White
The MHRA has granted a PIM designation for Novartis’ investigational medicine for patients with heart failure with reduced ejection fraction, LCZ696...
23 April 2015 | By Victoria White
Mobidiag, a molecular diagnostics company, will present two new diagnostic platforms – Novodiag and Amplidiag Easy – at ECCMID 2015...
23 April 2015 | By Victoria White
Now that ellaOne is available in UK Pharmacy without prescription, HRA Pharma UK is launching a training programme to support its introduction...
